
Jake Minh Vu
Examiner (ID: 8067, Phone: (571)272-8148 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1094 |
| Issued Applications | 354 |
| Pending Applications | 144 |
| Abandoned Applications | 625 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17110185
[patent_doc_number] => 20210290782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => METAL OXIDES NANOPARTICLES CONJUGATED WITH NAPHTHALENE DERIVATIVES AS CONTRAST AGENTS FOR THE DETECTION OF BETA AMYLOID PLAQUES BY MAGNETIC RESONANCE IMAGES
[patent_app_type] => utility
[patent_app_number] => 17/291996
[patent_app_country] => US
[patent_app_date] => 2019-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291996
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291996 | Metal oxides nanoparticles conjugated with naphthalene derivatives as contrast agents for the detection of beta amyloid plaques by magnetic resonance images | May 12, 2019 | Issued |
Array
(
[id] => 14712715
[patent_doc_number] => 20190247421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => COMPOSITION COMPRISING POLYGLUCOSAMINE-GLYOXYLATE SOLUTIONS MIXED WITH HYALURONAN
[patent_app_type] => utility
[patent_app_number] => 16/394125
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394125
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/394125 | Composition comprising polyglucosamine-glyoxylate solutions mixed with hyaluronan | Apr 24, 2019 | Issued |
Array
(
[id] => 14960861
[patent_doc_number] => 20190307908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => NANOEMULSION AGENTS FOR ULTRASOUND DIAGNOSTIC AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/374502
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16374502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/374502 | NANOEMULSION AGENTS FOR ULTRASOUND DIAGNOSTIC AND THERAPY | Apr 2, 2019 | Abandoned |
Array
(
[id] => 14863989
[patent_doc_number] => 20190282236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => CARBON NANOFIBER YARN NERVE SCAFFOLD
[patent_app_type] => utility
[patent_app_number] => 16/354975
[patent_app_country] => US
[patent_app_date] => 2019-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16354975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/354975 | CARBON NANOFIBER YARN NERVE SCAFFOLD | Mar 14, 2019 | Abandoned |
Array
(
[id] => 16498934
[patent_doc_number] => 10864301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Fabricating a carbon nanofiber yarn nerve scaffold
[patent_app_type] => utility
[patent_app_number] => 16/353608
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 43
[patent_no_of_words] => 12053
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/353608 | Fabricating a carbon nanofiber yarn nerve scaffold | Mar 13, 2019 | Issued |
Array
(
[id] => 14531635
[patent_doc_number] => 20190201438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => SUSTAINED-RELEASE COMPOSITION, METHOD FOR FABRICATING, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/299135
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299135
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299135 | SUSTAINED-RELEASE COMPOSITION, METHOD FOR FABRICATING, AND USE THEREOF | Mar 11, 2019 | Abandoned |
Array
(
[id] => 14806001
[patent_doc_number] => 20190269610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => SHORT DURATION DEPOT FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/297509
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16297509
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/297509 | Short duration depot formulations | Mar 7, 2019 | Issued |
Array
(
[id] => 14893347
[patent_doc_number] => 20190290439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => Multi-Layered Osteochondral Construct and Subchondral Bone Analog Thereof
[patent_app_type] => utility
[patent_app_number] => 16/292386
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16292386
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/292386 | Multi-Layered Osteochondral Construct and Subchondral Bone Analog Thereof | Mar 4, 2019 | Abandoned |
Array
(
[id] => 14497573
[patent_doc_number] => 20190192441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/289748
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289748
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289748 | ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS | Feb 28, 2019 | Abandoned |
Array
(
[id] => 15360815
[patent_doc_number] => 20200016172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => ORAL PHARMACEUTICAL PRODUCTS AND METHODS OF USE COMBINING TESTOSTERONE ESTERS WITH HYPOLIPIDEMIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/274968
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274968
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/274968 | ORAL PHARMACEUTICAL PRODUCTS AND METHODS OF USE COMBINING TESTOSTERONE ESTERS WITH HYPOLIPIDEMIC AGENTS | Feb 12, 2019 | Abandoned |
Array
(
[id] => 14712475
[patent_doc_number] => 20190247301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => GEL COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/269644
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269644
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/269644 | GEL COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF | Feb 6, 2019 | Abandoned |
Array
(
[id] => 14403483
[patent_doc_number] => 20190167585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Protective Effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC Against Drugs that Cause Channelopathies
[patent_app_type] => utility
[patent_app_number] => 16/246232
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/246232 | Protective Effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC Against Drugs that Cause Channelopathies | Jan 10, 2019 | Abandoned |
Array
(
[id] => 14306195
[patent_doc_number] => 20190142801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => USE OF SMALL MOLECULES FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE TOXICITY
[patent_app_type] => utility
[patent_app_number] => 16/241500
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241500
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241500 | USE OF SMALL MOLECULES FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE TOXICITY | Jan 6, 2019 | Abandoned |
Array
(
[id] => 19058996
[patent_doc_number] => 11938190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Herbal extracts for treatment of herpesvirus infections
[patent_app_type] => utility
[patent_app_number] => 16/959174
[patent_app_country] => US
[patent_app_date] => 2018-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8213
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959174
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959174 | Herbal extracts for treatment of herpesvirus infections | Dec 29, 2018 | Issued |
Array
(
[id] => 14464303
[patent_doc_number] => 20190183791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => SHORT DURATION DEPOT FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/235889
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16235889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/235889 | Short duration depot formulations | Dec 27, 2018 | Issued |
Array
(
[id] => 17281719
[patent_doc_number] => 11198740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Metal-containing oxidized cellulose nanofiber dispersion and method of producing the same
[patent_app_type] => utility
[patent_app_number] => 16/232234
[patent_app_country] => US
[patent_app_date] => 2018-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10495
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16232234
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/232234 | Metal-containing oxidized cellulose nanofiber dispersion and method of producing the same | Dec 25, 2018 | Issued |
Array
(
[id] => 16555834
[patent_doc_number] => 20210000982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => HYDROGEL COMPRISING MANGANESE, METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/956916
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956916 | HYDROGEL COMPRISING MANGANESE, METHODS AND USES THEREOF | Dec 20, 2018 | Abandoned |
Array
(
[id] => 17426943
[patent_doc_number] => 20220054651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => TERNARY MICELLAR COMPLEX COMPOSED OF A SIALOGLYCOSPHINGOLIPID, A THERAPEUTICALLY ACTIVE SUBSTANCE AND AN ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 17/413923
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17413923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/413923 | TERNARY MICELLAR COMPLEX COMPOSED OF A SIALOGLYCOSPHINGOLIPID, A THERAPEUTICALLY ACTIVE SUBSTANCE AND AN ANTIBODY | Dec 13, 2018 | Abandoned |
Array
(
[id] => 14210891
[patent_doc_number] => 20190117830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => IMPLANTABLE EMBOLIC SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 16/221224
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16221224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/221224 | IMPLANTABLE EMBOLIC SCAFFOLDS | Dec 13, 2018 | Abandoned |
Array
(
[id] => 14098957
[patent_doc_number] => 20190091154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES
[patent_app_type] => utility
[patent_app_number] => 16/210278
[patent_app_country] => US
[patent_app_date] => 2018-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16210278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/210278 | HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES | Dec 4, 2018 | Abandoned |